| 2022-06-27 6:27:25 am |
Merger Arbitrage Mondays: Zendesk To Be Acquired By Permira And Hellman & Friedman |
SeekingAlpha |
| Jun-17-22 07:00AM |
Sierra Oncology Announces Submission of New Drug Application for Momelotinib to US Food & Drug Administration |
Business Wire |
| May-26-22 05:00PM |
Momelotinib Pivotal Phase 3 Data Receives Oral Presentation at American Society of Clinical Oncology Annual Meeting |
Business Wire |
| May-12-22 10:00AM |
Sierra Oncology Announces Oral Presentation of Momelotinib Pivotal Phase 3 Data at European Hematology Association Annual Meeting |
Business Wire |
| May-06-22 07:00AM |
Sierra Oncology Reports First Quarter 2022 Results |
Business Wire |
| May-05-22 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Apr-14-22 01:34PM |
Biotech Stock Roundup: SRRA Surges on GSK Buyout, HALO Offers Update & More |
Zacks |
| Apr-13-22 04:44PM |
10 Hottest Stocks to Watch on Wednesday |
Insider Monkey |
| Apr-13-22 04:16PM |
Biotech Feeding Spree As GSK, Halozyme Announce Nearly $3 Billion In Deals |
Investor's Business Daily |
| Apr-13-22 11:52AM |
TBJ Plus: Cary gets new golf tournament; PPD Wilmington headquarters for sale; NC voters want legal weed |
American City Business Journals |
| Apr-13-22 11:42AM |
Why Is Sierra Oncology (SRRA) Stock Up Today? |
InvestorPlace |
| Apr-13-22 10:31AM |
GlaxoSmithKline to buy San Mateo-based Sierra Oncology for $1.9B |
American City Business Journals |
| Apr-13-22 10:28AM |
GlaxoSmithKline to buy California biotech firm Sierra Oncology for $1.9B |
American City Business Journals |
| Apr-13-22 10:18AM |
Glaxo (GSK) to Buy Sierra for $1.9B, Add Hematology Drug |
Zacks |
| Apr-13-22 09:40AM |
Sierra Oncology Stock Soars After $1.9 Billion Takeover by Glaxo |
Barrons.com |
| Apr-13-22 08:32AM |
GSK to buy Sierra Oncology for $1.9 billion |
MarketWatch |
| Apr-13-22 08:14AM |
Why Sierra Oncology Stock Is Soaring Today |
Motley Fool |
| Apr-13-22 07:53AM |
Midday Stock Movers: Delta, PayPal, AbbVie |
Investing.com |
| Apr-13-22 07:52AM |
GlaxoSmithKline Scoops Up Rare Cancer-Focused Sierra Oncology In $1.9B Cash Deal |
Benzinga |
| Apr-13-22 06:49AM |
GSK Agrees on $1.9bn Deal to Acquire Sierra Oncology |
Investing.com |
| Apr-13-22 04:21AM |
Sierra Oncology Stock Soars After $1.9 Billion Takeover by GlaxoSmithKline |
Barrons.com |
| Apr-13-22 02:48AM |
UPDATE 3-GSK to buy Sierra Oncology amid pressure to boost drug pipeline |
Reuters |
| Apr-13-22 02:27AM |
GlaxoSmithKline to Acquire Sierra Oncology for $1.9 Bln |
MarketWatch |
| Apr-13-22 02:21AM |
GSK to buy Sierra Oncology amid pressure to boost drug pipeline |
Reuters |
| Apr-13-22 02:05AM |
GSK Reaches Agreement to Acquire Late-Stage Biopharmaceutical Company Sierra Oncology For $1.9bn |
Business Wire |
| Apr-06-22 06:00PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Mar-28-22 08:32PM |
We're Keeping An Eye On Sierra Oncology's (NASDAQ:SRRA) Cash Burn Rate |
Simply Wall St. |
| Mar-14-22 06:36PM |
Oppenheimer Bets on These 2 Stocks; Sees Over 40% Upside Potential |
TipRanks |
| Mar-11-22 07:00AM |
Sierra Oncology to Participate in the Oppenheimer 32nd Annual Healthcare Conference |
Business Wire |
| Mar-10-22 07:00AM |
Sierra Oncology Reports 2021 Year End Results |
Business Wire |
| Mar-04-22 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Feb-18-22 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Feb-11-22 08:30PM |
Harley-Davidson, SOC Telemed Stocks See Action From Activist Investors |
Barrons.com |
| Feb-04-22 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Feb-03-22 04:05PM |
Sierra Oncology Announces Full Exercise of Underwriters Option to Purchase Additional Shares |
Business Wire |
| Feb-03-22 07:00AM |
Sierra Oncology to Participate in Guggenheim Oncology Conference |
Business Wire |
| Feb-02-22 09:19AM |
3 Monster Growth Stocks That Could Reach New Highs |
TipRanks |
| Jan-31-22 04:05PM |
Sierra Oncology Announces Closing of Upsized Public Offering of $135.0 Million of Securities |
Business Wire |
| Jan-27-22 09:18AM |
Sierra Oncology Raises $135M Via Equity To Fund Lead Program Development |
Benzinga |
| Jan-27-22 07:00AM |
Sierra Oncology to Present at B. Riley Securities Oncology Investor Conference |
Business Wire |
| Jan-26-22 11:05PM |
Sierra Oncology Announces Pricing of Upsized Public Offering of Securities |
Business Wire |
| Jan-25-22 06:21PM |
Why the stock of this small biotech with an underdog cancer drug climbed 46% |
American City Business Journals |
| Jan-25-22 04:08PM |
Sierra Oncology's Bet On A Failed Gilead Drug Just Paid Off In A Big Way |
Investor's Business Daily |
| Jan-25-22 04:01PM |
Sierra Oncology Announces Proposed Public Offering of Common Stock |
Business Wire |
| Jan-25-22 09:32AM |
Sierra Oncology Secures Debt Facility Of Up To $125M With Oxford Finance To Support Momelotinib Development |
Benzinga |
| Jan-25-22 09:12AM |
Why Sierra Oncology Stock Is On Fire Today |
Motley Fool |
| Jan-25-22 08:54AM |
Sierra Oncology Shares Rally As Bone Marrow Cancer Candidate Hits Primary Goal |
Benzinga |
| Jan-25-22 08:03AM |
What Kind Of Investors Own Most Of Sierra Oncology, Inc. (NASDAQ:SRRA)? |
Simply Wall St. |
| Jan-25-22 07:00AM |
Sierra Oncology's bone marrow cancer drug meets study main goal |
Reuters |
| Jan-25-22 07:00AM |
Sierra Oncology Provides Financial Update to Support the Future Commercialization of Momelotinib |
Business Wire |
| Jan-25-22 07:00AM |
Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis |
Business Wire |
| Jan-19-22 12:00PM |
Momelotinib Review Article Published in Journal of Hematology & Oncology Highlights Importance of Anemia Benefit for Myelofibrosis Patients |
Business Wire |
| Jan-18-22 07:00AM |
Sierra Oncology Updates Topline Data Timing for Pivotal Phase 3 Trial of Momelotinib in Myelofibrosis |
Business Wire |
| Jan-07-22 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Jan-05-22 07:00AM |
Sierra Oncology to Present at HC Wainwright BioConnect Conference |
Business Wire |
| Dec-13-21 06:34PM |
Sierra Oncology Reports Baseline Ferritin Differentially Predicts Week 24 Transfusion Independence Response in Myelofibrosis Patients |
Business Wire |
| Dec-06-21 07:00AM |
Sierra Oncology Announces Investor Event to Review MOMENTUM Trial Design and Available Phase 3 Momelotinib Data in Myelofibrosis |
Business Wire |
| Dec-03-21 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Nov-26-21 05:00AM |
Insider Buying: Craig Collard Just Spent US$311k On Sierra Oncology, Inc. (NASDAQ:SRRA) Shares |
Simply Wall St. |
| Nov-12-21 07:00AM |
Sierra Oncology Announces Presentation at Jefferies London Healthcare Conference |
Business Wire |
| Nov-10-21 04:15PM |
ORIC Pharmaceuticals Appoints Angie You, Ph.D., to its Board of Directors |
GlobeNewswire |
| Nov-05-21 07:00AM |
Sierra Oncology Reports Third Quarter 2021 Results |
Business Wire |
| Nov-04-21 09:00AM |
Sierra Oncology Announces Momelotinib Poster Accepted for Presentation at ASH |
Business Wire |
| Nov-03-21 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Oct-19-21 02:09PM |
A Sierra Oncology, Inc. (NASDAQ:SRRA) insider increased their holdings last year |
Simply Wall St. |
| Oct-04-21 04:14PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Sep-07-21 07:00AM |
Sierra Oncology to Present at Three September Investor Conferences |
Business Wire |
| Sep-03-21 04:05PM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Aug-09-21 07:00AM |
Sierra Oncology Provides Update to Momelotinib Development Timeline and Closes on $34 Million in Additional Funding |
Business Wire |
| Aug-05-21 04:10PM |
Sierra Oncology Reports Second Quarter 2021 Results |
Business Wire |
| Aug-05-21 04:05PM |
Sierra Oncology Signs Exclusive Global In-Licensing Agreement with AstraZeneca for Novel BET Inhibitor to Expand Myelofibrosis Pipeline |
Business Wire |
| Aug-05-21 07:00AM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Jul-22-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Jul-13-21 07:23AM |
Is Sierra Oncology (NASDAQ:SRRA) In A Good Position To Deliver On Growth Plans? |
Simply Wall St. |
| Jul-07-21 07:00AM |
Sierra Oncology Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) |
Business Wire |
| Jun-23-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
PR Newswire |
| Jun-23-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
CNW Group |
| Jun-21-21 07:00AM |
Sierra Oncology Announces Completion of Enrollment for MOMENTUM Phase 3 Trial |
PR Newswire |
| Jun-21-21 07:00AM |
Sierra Oncology Announces Completion of Enrollment for MOMENTUM Phase 3 Trial |
CNW Group |
| Jun-14-21 07:00AM |
Sierra Oncology Hosting KOL Panel Event to Discuss Momelotinib Data Presented at EHA 2021 |
PR Newswire |
| Jun-14-21 07:00AM |
Sierra Oncology Hosting KOL Panel Event to Discuss Momelotinib Data Presented at EHA 2021 |
CNW Group |
| Jun-11-21 03:00AM |
Momelotinib Oral Presentation at European Hematology Association Demonstrates Association Between Transfusion Independence and Improved Overall Survival |
PR Newswire |
| Jun-03-21 07:00AM |
Sierra Oncology Welcomes Two New Independent Directors to its Board |
PR Newswire |
| Jun-03-21 07:00AM |
Sierra Oncology Welcomes Two New Independent Directors to its Board |
CNW Group |
| May-25-21 07:00AM |
Sierra Oncology Announces Presentation at Jefferies Healthcare Conference |
PR Newswire |
| May-21-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
PR Newswire |
| May-21-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
CNW Group |
| May-19-21 05:00PM |
Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting |
CNW Group |
| May-12-21 10:00AM |
Sierra Oncology Announces Oral Presentation at European Hematology Association Annual Meeting |
PR Newswire |
| May-11-21 09:49AM |
Have Insiders Been Buying Sierra Oncology, Inc. (NASDAQ:SRRA) Shares? |
Simply Wall St. |
| May-07-21 07:00AM |
Sierra Oncology Reports First Quarter 2021 Results |
PR Newswire |
| May-07-21 07:00AM |
Sierra Oncology Reports First Quarter 2021 Results |
CNW Group |
| Mar-23-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
PR Newswire |
| Mar-23-21 07:00AM |
Sierra Oncology Announces Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) |
CNW Group |
| Mar-12-21 04:16AM |
Here's What Sierra Oncology, Inc.'s (NASDAQ:SRRA) Shareholder Ownership Structure Looks Like |
Simply Wall St. |
| Mar-11-21 07:00AM |
Sierra Oncology Reports 2020 Year End Results |
PR Newswire |
| Mar-11-21 07:00AM |
Sierra Oncology Reports 2020 Year End Results |
CNW Group |
| Mar-05-21 08:00AM |
/R E P E A T -- Media Advisory - Government of Canada to make Housing-Related Announcement in Winnipeg/ |
CNW Group |
| Mar-03-21 07:00AM |
Sierra Oncology to Present at Three Upcoming Investor Conferences |
PR Newswire |
| Mar-03-21 07:00AM |
Sierra Oncology to Present at Three Upcoming Investor Conferences |
CNW Group |
| Feb-12-21 07:00AM |
Sierra Oncology Announces Presentation at LifeSci Partners Precision Oncology Day |
PR Newswire |